Skip to main content
NGL Fine Chem Ltd. logo

NGL Fine Chem Ltd. — Investor Relations & Filings

Ticker · NGLFINE ISIN · INE887E01022 LEI · 335800X5TUU2OAV19X07 BSE.NS Manufacturing
Open in API
Filings indexed 308 across all filing types
Latest filing 2025-11-10 Call Transcript
Country IN India
Listing BSE.NS NGLFINE

About NGL Fine Chem Ltd.

https://www.nglfinechem.com

NGL Fine Chem Ltd. specializes in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates for both veterinary and human healthcare sectors. The company focuses on high-quality chemical synthesis, producing a diverse range of products including anthelmintics, ectoparasiticides, and specialty chemicals. Key products in its portfolio include Nitroxynil, Closantel, Oxyclozanide, and Triclabendazole. Operating with Good Manufacturing Practice (GMP) standards, the firm serves a global clientele, providing customized manufacturing solutions and maintaining a strong emphasis on research and development to enhance process efficiency and product quality. Its technical expertise lies in complex chemical reactions and large-scale production of niche pharmaceutical components.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 70% confidence The document is a notification to stock exchanges about a scheduled conference call with investors and analysts to discuss the company's unaudited financial results for the quarter and half year ended September 30, 2025. It includes details about the call timing, participants, and registration information. There is no actual financial data or detailed transcript included, only an announcement of the upcoming call. According to the classification rules, such a document is best classified as a Call Transcript (CT) only if it contains the full transcript, which this does not. It is also not an earnings release (ER) since it does not provide financial highlights, only a notice of the call. The document is not a report publication announcement (RPA) because it does not mention a report being attached or published. The best fit is a Call Transcript (CT) category as it relates to a conference call event, but since it is only an invitation and schedule notice, it is more accurately a Regulatory Filing (RNS) as a general regulatory announcement about the call. However, given the options and the nature of the document, the closest specific category is Call Transcript (CT) with moderate confidence, acknowledging it is an invitation rather than a transcript. Confidence is moderate at 0.7 due to the document being an announcement of a call rather than the transcript itself.
2025-11-10 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-11-03 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice informing the stock exchanges about the upcoming third Board Meeting of the financial year 2025-26. It states the meeting date and agenda, which includes approval of unaudited financial results for the quarter and half year ended September 30, 2025. The document is a formal announcement of a meeting, not the financial results themselves or any detailed report. It is short (1628 characters) and serves as a notification to regulators and investors about the meeting schedule and agenda. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement under SEBI regulations, rather than a financial report or other specific filing type.
2025-11-03 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories & Participants) Regulations, 2018, confirming the dematerialization of securities for the quarter ended 30th September 2025. It includes a detailed list of share certificates dematerialized during the period. The document is a compliance certificate related to securities dematerialization and does not contain financial statements, management discussion, or other report content. It is primarily a regulatory compliance certification submitted to stock exchanges. The document length is 4372 characters, which is relatively short and focused on certification rather than a full report. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory compliance certificate and not a financial report or announcement of a report.
2025-10-03 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notice from the company to stock exchanges about the closure of the trading window in compliance with insider trading regulations. It specifies the period during which trading in the company's securities is prohibited due to the upcoming declaration of audited financial results for the quarter ended September 30, 2025. The document does not contain any financial data, results, or detailed report content. It is an announcement related to trading restrictions ahead of financial results disclosure, not the financial report itself. The document length is short (1605 characters), and it serves as an official intimation to the exchanges. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-09-26 English
Shareholders meeting
Regulatory Filings
2025-08-19 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.